Commission Implementing Decision (EU) 2026/662

Contents

3,231 provisions, too many to show on one page. Open a part or section to read it with its history and connections, or search inside the text.

1. THE EUROPEAN COMMISSION, Having regard to the Treaty on the Functioning of the European Union, Having regard to Regulation (EU) 2016/429 of the European Parliam
   1. (1) Infection with lumpy skin disease virus is an infectious, vector-borne disease affecting bovine animals. Its occurrence can have a severe impact on the conc
   2. (2) Commission Delegated Regulation (EU) 2020/687 supplements the rules for the control of the listed diseases referred to in Article 9(1), points (a), (b) and
   3. (3) Commission Implementing Decision (EU) 2025/1708 lays down certain emergency measures related to outbreaks of infection with lumpy skin disease virus in Fran
   4. (4) Since the last amendment of Implementing Decision (EU) 2025/1708 by Commission Implementing Decision (EU) 2026/393, no additional outbreaks of infection wit
   5. (5) In light of the evolving epidemiological situation, in particular the new outbreaks of lumpy skin disease virus confirmed in Spain, the areas listed as prot
   6. (6) The size of the areas indicated as protection and surveillance zones, and the duration of the measures to be applied therein, are based on the criteria laid
   7. (7) The vaccination zones established in Annex II to Implementing Decision (EU) 2025/1708 remain necessary, and vaccination should continue in accordance with F
   8. (8) The type, size and duration of vaccination zones I and II set out in Parts B and A of Annex II to Implementing Decision (EU) 2025/1708 are based on the epid
   9. (9) Article 2 of Implementing Decision (EU) 2025/1708 prohibits the movements of bovine animals from the protection and surveillance zones set out in Annex I to
   10. (10) Given the updated restricted zones in the department of Hautes-Pyrénées, in France, it is necessary to adjust the vaccination zones I and II for infection
   11. (11) The Annexes to Implementing Decision (EU) 2025/1708 should, therefore, be amended accordingly.
   12. (12) In light of the current epidemiological situation in France as regards infection with lumpy skin disease virus, the amendments to be made to Annexes I and
   13. (13) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,
2. 1
3. 2
4. I · Protection and surveillance zones established around the confirmed outbreaks
   1. Administrative area and ADIS reference number of the outbreak Areas established as protection and surveillance zones, part of the restricted zone, referred to i
5. II
   1. Part A: Vaccination zone II
   2. Part B: Vaccination zone I
6. anx_1
   1. ‘ ’